Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pusineri

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Kidney International. Supplement|March 1, 1988
Coagulation defects in uremiaG Remuzzi, F Pusineri
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1984
The lupus anticoagulantN Perico, F Pusineri, G Remuzzi
Journal of Clinical Pathology|July 1, 1980
Intermittent heparin treatment does not induce hypercoagulability in haemodialysed patientsF Pusineri, A Bini, L Mussoni, et al.
Kidney International|December 1, 1988
Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremiaG Viganò, F Gaspari, M Locatelli, et al.
The International Journal of Artificial Organs|March 1, 1980
Platelets from uraemic patients react normally to prostacyclinF Pusineri, E Gotti, G Remuzzi, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1990
17 beta-estradiol is the most active component of the conjugated estrogen mixture active on uremic bleeding by a receptor mechanismG Viganò, C Zoja, D Corna, et al.
The New England Journal of Medicine|January 6, 1983
Deamino-8-D-arginine vasopressin shortens the bleeding time in uremiaP M Mannucci, G Remuzzi, F Pusineri, et al.
The International Journal of Artificial Organs|September 1, 1984
Heparin for hemodialysis: practical guidelines for administration and monitoringG Mingardi, N Perico, F Pusineri, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Kidney International. Supplement|March 1, 1988
Coagulation defects in uremiaG Remuzzi, F Pusineri
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1984
The lupus anticoagulantN Perico, F Pusineri, G Remuzzi
Journal of Clinical Pathology|July 1, 1980
Intermittent heparin treatment does not induce hypercoagulability in haemodialysed patientsF Pusineri, A Bini, L Mussoni, et al.
Kidney International|December 1, 1988
Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremiaG Viganò, F Gaspari, M Locatelli, et al.
The International Journal of Artificial Organs|March 1, 1980
Platelets from uraemic patients react normally to prostacyclinF Pusineri, E Gotti, G Remuzzi, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1990
17 beta-estradiol is the most active component of the conjugated estrogen mixture active on uremic bleeding by a receptor mechanismG Viganò, C Zoja, D Corna, et al.
The New England Journal of Medicine|January 6, 1983
Deamino-8-D-arginine vasopressin shortens the bleeding time in uremiaP M Mannucci, G Remuzzi, F Pusineri, et al.
The International Journal of Artificial Organs|September 1, 1984
Heparin for hemodialysis: practical guidelines for administration and monitoringG Mingardi, N Perico, F Pusineri, et al.
Pageof 1